The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CD8 radiomics signature to assess inter-lesion spatial heterogeneity and cold liver lesions in advanced non-small cell lung cancers treated with durvalumab.
 
Roger Sun
Research Funding - AstraZeneca (Inst)
Patents, Royalties, Other Intellectual Property - CD8 radiomics score patented
 
Yanis Emeriau
No Relationships to Disclose
 
Samir Achkar
No Relationships to Disclose
 
Diana Mitrea
No Relationships to Disclose
 
Adrien Laville
No Relationships to Disclose
 
Nicolas Deny
No Relationships to Disclose
 
Sophie Bockel
No Relationships to Disclose
 
Ines Chaffai
No Relationships to Disclose
 
Linda Mrissa
No Relationships to Disclose
 
Vjona Cifliku
No Relationships to Disclose
 
Fereshteh Talebi
No Relationships to Disclose
 
Wenxia Wu
No Relationships to Disclose
 
Cecile Le Pechoux
Honoraria - Medscape; Prime Oncology
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb; Roche (Inst)
Travel, Accommodations, Expenses - Janssen
 
Fabrice Barlesi
Consulting or Advisory Role - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai Europe (Inst); Lilly (Inst); Merck Serono (Inst); Mirati Therapeutics (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Innate Pharma (Inst); Innate Pharma (Inst); Ipsen (Inst); Lilly (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst); Sanofi/Aventis (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Charlotte Robert
No Relationships to Disclose
 
Antonin Levy
No Relationships to Disclose
 
Eric Deutsch
Honoraria - AstraZeneca; Boehringer Ingelheim; Roche/Genentech
Consulting or Advisory Role - AstraZeneca (Inst); Merck Serono
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - CD8 radiomic score patented
Travel, Accommodations, Expenses - AstraZeneca